Souvenaid

Souvenaid is a treatment for Alzheimer's disease developed by Danone research consisting of a cocktail of nutrients including uridine monophosphate, choline, the omega-3 fatty acids EPA and DHA, phospholipids, B vitamins and antioxidants.

The results of its first clinical trials were announced at the Alzheimer's Association International Conference on Alzheimer's Disease (ICAD) in July 2008. [ [http://www.alz.org/icad/_release_icad_072908_130pm_trials.asp ICAD Press Release] ]

The basic ideas behind this treatment were developed by Prof. Richard Wurtman of M.I.T.

Notes